You are here: Industry Insights > cancer

News List

Study shows certain genetic faults help predict immunotherapy success in cancer pharmaceutical-technology
June 14, 2017
New research conducted by John Hopkins University in Baltimore, US, has found that a certain group of genetic faults can be used to predict the success of immunotherapy in cancer patients.
Cancer vaccine developer Targovax pulls in €21M in private placement fiercepharma
June 14, 2017
Norwegian biotech Targovax has raised about €21 million in a private placement as it works to advance prostate cancer vaccine TG01 and other programs against a variety of cancers.
Genomic Health: New Data Show Important Role of Genomic Testing in Treatment of Older Breast Cancer b3cnewswire
June 13, 2017
Genomic Health announced results from an analysis of patients with hormone-receptor-positive (HR+), early-stage breast cancer at the American Society for Clinical Oncology (ASCO) annual meeting.
Interview – German Merck doubles down on dual-acting cancer agents epvantage
June 13, 2017
Pfizer andnclick=getInfo('1042'); return false;Merck KGaAsuccessfully got thenclick=storyWordlink('PD-L1'
An improved tool to detect cancer biospectrumasia
June 12, 2017
The real innovation here is that the researchers have converted something that was discovered in an infectious disease research program into food poisoning and were able to utilize it as a tool for potentially detecting tumor antigens.
UK’s first cancer fighting proton beam therapy system arrives in Wales europeanpharmaceuticalreview
May 26, 2017
The first high energy proton beam therapy system to be installed in the UK has arrived at The Rutherford Cancer Centre, South Wales.
Shareholder suit targets NewLink management over failed cancer vaccine trial fiercepharma
May 25, 2017
A year after NewLink Genetics reported a phase 3 trial failure for its pancreatic cancer vaccine that crushed shares, a shareholder is taking it to the company’s current and former execs for “gross mismanagement” and other allegations.
ICR track cancer to ‘carbon date’ progression pharmafiles
May 12, 2017
The Institute of Cancer Research (ICR) has collaborated with sites across Scotland, Italy and the US to study the disease progression of a single patient with metastatic bowel cancer.
VolitionRx Limited Announces Final Results from 8000 Patient Clinical Trial in Denmark to Evaluate t en-cphi.cn
May 10, 2017
New data confirms prior test results that Volition's novel blood test can accurately detect colorectal cancer and reduce colonoscopies
Immunocore and GSK identify second new ImmTAC for cancer treatment pharmaceutical-technology
May 09, 2017
UK-based biotechnology firm Immunocore and GlaxoSmithKline (GSK) have identified a lead compound as part of their second discovery programme.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page